Annual Current Assets
$20.13 M
-$23.35 M-53.71%
December 31, 2022
Summary
- As of February 8, 2025, ELOX annual total current assets is $20.13 million, with the most recent change of -$23.35 million (-53.71%) on December 31, 2022.
- During the last 3 years, ELOX annual current assets has fallen by -$37.58 million (-65.12%).
- ELOX annual current assets is now -65.12% below its all-time high of $57.71 million, reached on December 31, 2019.
Performance
ELOX Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$5.63 M
+$247.00 K+4.59%
September 30, 2023
Summary
- As of February 8, 2025, ELOX quarterly total current assets is $5.63 million, with the most recent change of +$247.00 thousand (+4.59%) on September 30, 2023.
- Over the past year, ELOX quarterly current assets has dropped by -$20.04 million (-78.07%).
- ELOX quarterly current assets is now -92.76% below its all-time high of $77.74 million, reached on June 30, 2019.
Performance
ELOX Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
ELOX Current Assets Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -53.7% | -78.1% |
3 y3 years | -65.1% | -82.5% |
5 y5 years | -17.9% | -88.8% |
ELOX Current Assets Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -53.7% | at low | -87.0% | +4.6% |
5 y | 5-year | -65.1% | at low | -90.4% | +4.6% |
alltime | all time | -65.1% | -100.0% | -92.8% | >+9999.0% |
Eloxx Pharmaceuticals Current Assets History
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | $5.63 M(+4.6%) |
Jun 2023 | - | $5.38 M(-15.9%) |
Mar 2023 | - | $6.40 M(-68.2%) |
Dec 2022 | $994.00 K(-40.1%) | $20.13 M(-21.6%) |
Sep 2022 | - | $25.67 M(-18.7%) |
Jun 2022 | - | $31.59 M(-25.0%) |
Mar 2022 | - | $42.15 M(-3.1%) |
Dec 2021 | $1.66 M(+184.1%) | $43.48 M(-18.8%) |
Sep 2021 | - | $53.54 M(-8.6%) |
Jun 2021 | - | $58.56 M(+193.4%) |
Mar 2021 | - | $19.96 M(-22.9%) |
Dec 2020 | $584.00 K(-52.8%) | $25.89 M(-19.6%) |
Sep 2020 | - | $32.21 M(-17.3%) |
Jun 2020 | - | $38.97 M(-15.2%) |
Mar 2020 | - | $45.93 M(-20.4%) |
Dec 2019 | $1.24 M(+228.4%) | $57.71 M(-13.7%) |
Sep 2019 | - | $66.85 M(-14.0%) |
Jun 2019 | - | $77.74 M(+40.2%) |
Mar 2019 | - | $55.46 M(+10.2%) |
Dec 2018 | $377.00 K(+35.6%) | $50.34 M(-10.3%) |
Sep 2018 | - | $56.14 M(-12.2%) |
Jun 2018 | - | $63.97 M(+239.5%) |
Mar 2018 | - | $18.84 M(+1714.3%) |
Dec 2017 | $278.00 K(-95.0%) | - |
Sep 2017 | - | $1.04 M(+265.2%) |
Jun 2017 | - | $284.40 K(+4.4%) |
Jun 2017 | $5.56 M(-32.5%) | - |
Mar 2017 | - | $272.30 K(+36.3%) |
Dec 2016 | - | $199.80 K(-46.8%) |
Sep 2016 | - | $375.90 K(-61.7%) |
Jun 2016 | $8.24 M(-47.9%) | $982.60 K(-38.7%) |
Mar 2016 | - | $1.60 M(-40.3%) |
Dec 2015 | - | $2.69 M(-26.4%) |
Sep 2015 | - | $3.65 M(-2.0%) |
Jun 2015 | $15.82 M(-39.4%) | $3.73 M(+523.6%) |
Mar 2015 | - | $598.10 K(-74.8%) |
Dec 2014 | - | $2.37 M(-41.3%) |
Sep 2014 | - | $4.04 M(-44.0%) |
Jun 2014 | $26.11 M(+630.1%) | $7.22 M(-2.3%) |
Mar 2014 | - | $7.40 M(-2.8%) |
Dec 2013 | - | $7.61 M(+223.1%) |
Sep 2013 | - | $2.36 M(-33.1%) |
Jun 2013 | $3.58 M(+5.0%) | $3.52 M(+6.9%) |
Mar 2013 | - | $3.29 M(+70.1%) |
Dec 2012 | - | $1.94 M(-30.2%) |
Sep 2012 | - | $2.77 M(-21.9%) |
Jun 2012 | $3.40 M(-3.8%) | $3.55 M(-28.2%) |
Mar 2012 | - | $4.94 M(+54.0%) |
Dec 2011 | - | $3.21 M(-31.2%) |
Sep 2011 | - | $4.67 M(-7.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2011 | $3.54 M(-22.7%) | $5.06 M(-18.2%) |
Mar 2011 | - | $6.18 M(+0.6%) |
Dec 2010 | - | $6.15 M(-15.6%) |
Sep 2010 | - | $7.28 M(-22.0%) |
Jun 2010 | $4.58 M(+1.1%) | $9.33 M(+527.7%) |
Mar 2010 | - | $1.49 M(-37.7%) |
Dec 2009 | - | $2.38 M(-7.7%) |
Sep 2009 | - | $2.58 M(-0.3%) |
Jun 2009 | $4.53 M(+5.7%) | $2.59 M(-27.3%) |
Mar 2009 | - | $3.57 M(-19.7%) |
Dec 2008 | - | $4.44 M(-21.9%) |
Sep 2008 | - | $5.69 M(-10.5%) |
Jun 2008 | $4.29 M(+67.5%) | $6.36 M(+38.0%) |
Mar 2008 | - | $4.61 M(-19.0%) |
Dec 2007 | - | $5.69 M(+220.8%) |
Sep 2007 | - | $1.77 M(+132.5%) |
Jun 2007 | $2.56 M(+14.9%) | $762.60 K(-42.1%) |
Mar 2007 | - | $1.32 M(-37.8%) |
Dec 2006 | - | $2.12 M(+137.3%) |
Sep 2006 | - | $893.00 K(-31.7%) |
Jun 2006 | $2.23 M(+29.3%) | $1.31 M(-49.6%) |
Mar 2006 | - | $2.59 M(-16.2%) |
Dec 2005 | - | $3.10 M(-19.5%) |
Sep 2005 | - | $3.84 M(-12.4%) |
Jun 2005 | $1.72 M(+75.6%) | $4.39 M(+85.9%) |
Mar 2005 | - | $2.36 M(-24.3%) |
Dec 2004 | - | $3.12 M(-11.6%) |
Sep 2004 | - | $3.53 M(-16.6%) |
Jun 2004 | $981.10 K(+48.4%) | $4.23 M(-8.5%) |
Mar 2004 | - | $4.62 M(+180.7%) |
Dec 2003 | - | $1.65 M(-20.9%) |
Sep 2003 | - | $2.08 M(-20.0%) |
Jun 2003 | $661.20 K(-53.7%) | $2.60 M(-20.9%) |
Mar 2003 | - | $3.29 M(-13.1%) |
Dec 2002 | - | $3.79 M(-3.3%) |
Sep 2002 | - | $3.92 M(+3.1%) |
Jun 2002 | $1.43 M(+485.6%) | $3.80 M(+8.7%) |
Mar 2002 | - | $3.50 M(+23.8%) |
Dec 2001 | - | $2.83 M(+4435.3%) |
Sep 2001 | - | $62.30 K(+108.4%) |
Jun 2001 | $243.90 K(+36.3%) | $29.90 K(-91.2%) |
Mar 2001 | - | $339.20 K(-46.0%) |
Dec 2000 | - | $628.40 K(-44.3%) |
Sep 2000 | - | $1.13 M(-27.9%) |
Jun 2000 | $178.90 K(+42.5%) | $1.56 M(+769.4%) |
Mar 2000 | - | $180.00 K(+80.0%) |
Dec 1999 | - | $100.00 K |
Jun 1999 | $125.50 K(>+9900.0%) | - |
Jun 1998 | $0.00(0.0%) | - |
Jun 1997 | $0.00 | - |
FAQ
- What is Eloxx Pharmaceuticals annual total current assets?
- What is the all time high annual current assets for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals annual current assets year-on-year change?
- What is Eloxx Pharmaceuticals quarterly total current assets?
- What is the all time high quarterly current assets for Eloxx Pharmaceuticals?
- What is Eloxx Pharmaceuticals quarterly current assets year-on-year change?
What is Eloxx Pharmaceuticals annual total current assets?
The current annual current assets of ELOX is $20.13 M
What is the all time high annual current assets for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high annual total current assets is $57.71 M
What is Eloxx Pharmaceuticals annual current assets year-on-year change?
Over the past year, ELOX annual total current assets has changed by -$23.35 M (-53.71%)
What is Eloxx Pharmaceuticals quarterly total current assets?
The current quarterly current assets of ELOX is $5.63 M
What is the all time high quarterly current assets for Eloxx Pharmaceuticals?
Eloxx Pharmaceuticals all-time high quarterly total current assets is $77.74 M
What is Eloxx Pharmaceuticals quarterly current assets year-on-year change?
Over the past year, ELOX quarterly total current assets has changed by -$20.04 M (-78.07%)